Scott Duncan
Director
management
Trillium Therapeutics
Canada
Biography
Mr. Duncan is recognized for the quality of his patent consulting services which he has provided for the past 30 years to a diverse range of biotechnology companies since he built and managed Canada’s largest biotech patent estate during his tenure with Allelix, one of Canada's initial biotech companies that was acquired by NPS Pharmaceuticals. His responsibilities within that role included the development of patent assets relating to transgenic crops, medicinal chemistry, protein drugs and expression systems, and in vitro diagnostics. Mr. Duncan has been a registered patent agent since 1986, when he qualified magna cum laude while working at a Toronto firm specializing in intellectual property.
Research Interest
Intellectual Property, patent consulting services
